Table 1.
Patient demographics and tumor characteristics by treatment arm
| Standard (N = 16) |
Experimental (N = 14) |
Total (N = 30) |
p value | |
|---|---|---|---|---|
| Median age, years (range) | 57.2 (39.6–74.9) | 53.1 (27.8–69.7) | 54.7 (27.8–74.9) | 0.42 |
| Race/ethnicity | 0.71 | |||
| Caucasian | 11 (68.8%) | 7 (50.0%) | 18 (60.0%) | |
| Hispanic | 4 (25.0%) | 5 (35.7%) | 9 (30.0%) | |
| African American | 0 (0.0%) | 1 (7.1%) | 1 (3.3%) | |
| Asian | 1 (6.3%) | 1 (7.1%) | 2 (6.7%) | |
| Tumor type | 0.21 | |||
| Invasive ductal carcinoma | 16 (100%) | 12 (85.7%) | 28 (93.3%) | |
| Invasive lobular carcinoma | 0 (0.0%) | 1 (7.1%) | 1 (3.3%) | |
| Invasive mammary carcinoma | 0 (0.0%) | 1 (7.1%) | 1 (3.3%) | |
| Stage | 0.72 | |||
| Stage II | 7 (43.8%) | 8 (57.1%) | 15 (50.0%) | |
| Stage III | 9 (56.3%) | 6 (42.9%) | 15 (50.0%) | |
| Hormone status | ||||
| ER negative | 8 (50%) | 6 (43%) | 14 (46.6%) | |
| ER positive | 8 (50%) | 8 (57.1%) | 16 (53.3%) | |
| Grade | 0.27 | |||
| Grade 2 | 5 (31.3%) | 8 (57.1%) | 13 (43.3%) | |
| Grade 3 | 11 (68.8%) | 6 (42.9%) | 17 (56.7%) | |
| Ki-67 | 50.5 (2--80) | 55.9 (15–80) | 53.2 (15–80) | 0.54 |